• Financial disclosure is required for all types of submissions.
• Authors are expected to provide detailed information about any relevant financial interests or financial conflicts within the past 5 years and for the foreseeable future.
• Authors who have no relevant financial interests are asked to provide a statement indicating that they have no financial interests related to the material in the manuscript.

Example:

• Dr de Lemos reported receiving research grants and honoraria and consulting fees for speaking from Biosite and Roche. Dr Blazing reported receiving honoraria from Merck and Pfizer.